Related Experiment Video
Updated: Aug 10, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
Triglycerides: risk factor or fellow traveler?
1Division of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA. forrester@cshs.org
Insights
Serum triglyceride levels are increasingly recognized as an independent risk factor for coronary heart disease. New evidence clarifies their diagnostic value and informs triglyceride-lowering therapy strategies.
Area of Science:
- Preventive Cardiology
- Cardiovascular Risk Assessment
- Lipid Metabolism
Background:
- The role of serum triglycerides as an independent risk factor for coronary heart disease (CHD) remains a key unresolved issue in preventive cardiology.
- Clarifying the diagnostic utility of triglyceride levels is crucial for clinical practice.
Purpose of the Study:
- To review current evidence on the importance of triglycerides as a risk factor for coronary heart disease.
- To discuss the implications of recent lipid-lowering clinical trials.
- To explore alternative triglyceride-lowering therapies based on new knowledge.
Main Methods:
- Review of recent scientific evidence and clinical trial data.
- Analysis of the association between serum triglyceride levels and coronary heart disease.
- Evaluation of therapeutic strategies for lipid lowering.
Main Results:
- Recent evidence substantially clarifies the role of triglycerides in CHD.
- New data informs the diagnostic value of triglyceride levels.
- Implications for lipid-lowering therapies are discussed.
Conclusions:
- Serum triglyceride levels are an important independent risk factor for coronary heart disease.
- Triglyceride levels hold diagnostic value in cardiovascular risk assessment.
- Updated knowledge guides the selection of triglyceride-lowering therapies.
Abstract:
An unresolved issue in preventive cardiology is whether the serum triglyceride level is an independent risk factor for coronary heart disease and, as a direct practical consequence, whether it has value as a diagnostic test. Evidence published in the past year has contributed substantially to clarifying these issues. In this review, we discuss the data that bears upon the importance of triglycerides as a risk factor and the implications of recent clinical trials directed at lipid lowering. We then discuss the alternatives for triglyceride lowering therapy in the light of this new knowledge.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management
Type II Diabetes I: Introduction
